These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9546713)

  • 1. Hypertension, lipid abnormalities and cardiovascular changes in autosomal dominant polycystic kidney disease.
    Polat H; Karayaylali I; Niyazova Z; Seyrek N; Paydaş S; Sagliker Y
    Nephron; 1998; 78(3):369-71. PubMed ID: 9546713
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of renin-angiotensin-aldosterone system and of sympathetic activity in arterial hypertension associated with autosomal dominant polycystic kidney disease.
    Cerasola G; Li Vecchi M; Mulé G; Cottone S; Mangano MT; Andronico G; Contomo A; Parrino IA; Renda F; Pavone G; Scialabba A
    Contrib Nephrol; 1997; 122():22-7. PubMed ID: 9399032
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypertension in autosomal dominant polycystic kidney disease.
    Chapman AB; Gabow PA
    Kidney Int Suppl; 1997 Oct; 61():S71-3. PubMed ID: 9328971
    [No Abstract]   [Full Text] [Related]  

  • 4. Autosomal-dominant polycystic kidney disease and hypertension: a review.
    Florijn KW; van Saase JL; Breuning MH; Chang PC
    Contrib Nephrol; 1992; 97():71-92. PubMed ID: 1386018
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypertension in autosomal-dominant polycystic kidney disease: early occurrence and unique aspects.
    Ecder T; Schrier RW
    J Am Soc Nephrol; 2001 Jan; 12(1):194-200. PubMed ID: 11134267
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypertension in autosomal dominant polycystic kidney disease: is renin acquitted as a culprit?
    Ritz E
    J Hypertens; 2006 Jun; 24(6):1023-5. PubMed ID: 16685200
    [No Abstract]   [Full Text] [Related]  

  • 7. Red blood cell Na(+)-K+ pump activity and arterial hypertension in autosomal dominant polycystic kidney disease.
    Boero R; Guarena C; Carbone D; Piccoli G
    Nephron; 1996; 72(2):321. PubMed ID: 8684549
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypertension in autosomal dominant polycystic kidney disease.
    Parfrey PS; Barrett BJ
    Curr Opin Nephrol Hypertens; 1995 Sep; 4(5):460-4. PubMed ID: 8564453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis and treatment of hypertension in polycystic kidney disease.
    Neumann J; Ligtenberg G; Klein IH; Blankestijn PJ
    Curr Opin Nephrol Hypertens; 2002 Sep; 11(5):517-21. PubMed ID: 12187316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sympathetic activity and blood pressure pattern in autosomal dominant polycystic kidney disease hypertensives.
    Cerasola G; Vecchi M; Mulè G; Cottone S; Mangano MT; Andronico G; Contorno A; Parrino I; Renda F; Pavone G
    Am J Nephrol; 1998; 18(5):391-8. PubMed ID: 9730562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension and left ventricular hypertrophy in autosomal dominant polycystic kidney disease.
    Ecder T; Schrier RW
    Expert Rev Cardiovasc Ther; 2004 May; 2(3):369-74. PubMed ID: 15151483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in induced potassium calcium efflux in the erythrocytes of patients with autosomal dominant polycystic kidney disease and hypertension.
    Buemi M; Allegra A; Marino D; Marino MT; Aloisi C; Casuscelli T; Frisina N; Corica F
    Nephron; 1997; 76(3):369-70. PubMed ID: 9226251
    [No Abstract]   [Full Text] [Related]  

  • 13. Interpretation of renal volume in autosomal dominant polycystic kidney disease and relevant clinical implications.
    Masoumi A; Elhassan E; Schrier RW
    Iran J Kidney Dis; 2011 Jan; 5(1):1-8. PubMed ID: 21189426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polycystic kidney disease presenting with hypertension and hypokalemia.
    Chow KM; Ma RC; Szeto CC; Li PK
    Am J Kidney Dis; 2012 Feb; 59(2):270-2. PubMed ID: 21962616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiovascular risk in polycystic kidney disease].
    Di Lorenzo A; Stallone G; Infante B; Grandaliano G; Schena FP
    G Ital Cardiol (Rome); 2015 Sep; 16(9):479-84. PubMed ID: 26418387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiovascular disorders in autosomal dominant polycystic kidney disease].
    Hamzaoui M; Lamy G; Bellien J; Guerrot D
    Nephrol Ther; 2021 Feb; 17(1):18-29. PubMed ID: 33431311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autosomal dominant polycystic kidney disease and hypertension in the aviator.
    Fox KA; Rudge FW
    Aviat Space Environ Med; 1996 Apr; 67(4):376-8. PubMed ID: 8900993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal artery occlusion in autosomal dominant polycystic kidney disease.
    Sánchez M; Enríquez R; Sirvent AE; Millan I; de la Iglesia P; Amorós F
    Ren Fail; 2014 Aug; 36(7):1142-4. PubMed ID: 24827072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease.
    Schrier RW
    J Am Soc Nephrol; 2009 Sep; 20(9):1888-93. PubMed ID: 19696226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma concentration of endothelin and arterial pressure in patients with ADPKD.
    Giusti R; Neri M; Angelini D; Carlini A; Fiorini I; Bigongiari P; Antonelli A
    Contrib Nephrol; 1995; 115():118-21. PubMed ID: 8585897
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.